In the case of moderate-to-severe psoriasis is often performed anti-inflammatory therapy with biologics. With a new method, researchers were able to demonstrate that this treatment also reduces blood vessels inflammation on the coronary heart. For people with other chronic inflammatory diseases, biological therapies could also be useful.
The scientists used for the investigation of a new Biomarker called FAI (from the English fat attenuation index), measured by computed tomography: an inflammation of the cardiac blood vessels, the fatty tissue is deposited in the immediate surroundings, less fat, what is in the CT visible. In 134 patients the FAI was measured twice at an interval of one year. In the case of those who had receive a biological therapy for Psoriasis, the inflammation of the coronary arteries in the control group there was no change. Even in patients with deposits in the coronary arteries, the inflammation decreased.
"The inflammation of the coronary arteries provides important information on the risk of heart disease entwickeln", the cardiologist Dr. Nehal N. Mehta said. "Our findings add to the growing number of research reports suggest that the treatment of inflammatory diseases can reduce the risk for cardiovascular disease." So also people with other chronic, could benefit inflammatory diseases such as systemic Lupus erythematosus and rheumatoid Arthritis, and of such a treatment in a double sense.
Psoriasis, also psoriasis is a common skin disease that is accompanied by a General inflammation, which increases the risk for vascular disease and Diabetes.